HUP0102773A2 - Antikonvulzáns hatású tetrahidronaftiridinil-karboxamidok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények - Google Patents
Antikonvulzáns hatású tetrahidronaftiridinil-karboxamidok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítményekInfo
- Publication number
- HUP0102773A2 HUP0102773A2 HU0102773A HUP0102773A HUP0102773A2 HU P0102773 A2 HUP0102773 A2 HU P0102773A2 HU 0102773 A HU0102773 A HU 0102773A HU P0102773 A HUP0102773 A HU P0102773A HU P0102773 A2 HUP0102773 A2 HU P0102773A2
- Authority
- HU
- Hungary
- Prior art keywords
- group
- hydrogen atom
- alkyl
- sulfonyl
- carbonyl
- Prior art date
Links
- 230000001773 anti-convulsant effect Effects 0.000 title abstract 2
- 239000001961 anticonvulsive agent Substances 0.000 title abstract 2
- 229960003965 antiepileptics Drugs 0.000 title abstract 2
- 230000000694 effects Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- -1 nitro- Chemical class 0.000 abstract 12
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 5
- 125000003545 alkoxy group Chemical group 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 125000003282 alkyl amino group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000000304 alkynyl group Chemical group 0.000 abstract 2
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 abstract 2
- 125000004663 dialkyl amino group Chemical group 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 125000003884 phenylalkyl group Chemical group 0.000 abstract 2
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 abstract 2
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 abstract 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 125000004429 atom Chemical group 0.000 abstract 1
- 125000002837 carbocyclic group Chemical group 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000000000 cycloalkoxy group Chemical group 0.000 abstract 1
- 125000006254 cycloalkyl carbonyl group Chemical group 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000005112 cycloalkylalkoxy group Chemical group 0.000 abstract 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 abstract 1
- 125000001841 imino group Chemical group [H]N=* 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 abstract 1
- 125000005010 perfluoroalkyl group Chemical group 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychology (AREA)
- Virology (AREA)
- Anesthesiology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Hospice & Palliative Care (AREA)
- Immunology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
A találmány antikonvulzív hatású (I) általános képletű vegyületekre,gyógyászatilag elfogadható sóikra és szolvátjaikra vonatkozik, amelyekképletében R1 hidrogénatom, alkilcsoport, amely adott esetben hidroxi-vagy alkoxicsoporttal szubsztituált, fenil-alkil-, alkenil- vagyalkinilcsoport: R2 hidrogénatom, vagy legfeljebb három, a következőatomok és/vagy csoportok közül kiválasztott szubsztituens:halogénatom, nitro-, ciano-, azido-, trifluor-metoxi-, (trifluor-metil)-tio-, (trifluor-metil)-szulfonil-, trifluor-acetil-, alkil-,alkenil-, alkinil-, perfluor-alkil-, cikloalkil-, cikloalkil-alkil-,alkoxi-, alkil-karbonil-, cikloalkil-oxi-, cikloalkil-karbonil-,cikloalkil-alkoxi-, (cikloalkil-alkil)-karbonil-, fenil-, fenoxi-,benzil-oxi-, benzoil-, fenil-alkil-, alkil-tio-, alkil-szulfonil-,(dialkil-amino)-szulfonil-, (alkil-amino)-szulfonil-, (dialkil-amino)-karbonil-, (alkil-amino)-karbonil-, karbamoil-, vagy -NR5R6 csoport,vagy két R2 telített vagy telítetlen, adott esetben oxi- vagyiminocsoporttal megszakított karbociklusos csoportot képez; R3 és R4hidrogénatom vagy alkilcsoport, vagy a két R3 és/vagy a két R4 együttspiroalkilcsoportot képez, azzal a megkötéssel, hogy legalább egy R3és R4 csoport jelentése hidrogénatomtól eltérő: és X hidrogén-,halogénatom, ciano-, alkil- vagy alkoxicsoport. A találmány kiterjed avegyületek előállítási eljárásaira, továbbá a vegyületekethatóanyagként tartalmazó idegrendszeri betegségek kezelésére és/vagymegelőzésére szolgáló gyógyszerkészítményekre is. Ó
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9812683.2A GB9812683D0 (en) | 1998-06-12 | 1998-06-12 | Novel compounds |
| PCT/GB1999/001826 WO1999065903A1 (en) | 1998-06-12 | 1999-06-09 | Tetrahydronaphthyridinyl-carboxamides having anti-convulsant activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0102773A2 true HUP0102773A2 (hu) | 2002-01-28 |
| HUP0102773A3 HUP0102773A3 (en) | 2002-09-30 |
Family
ID=10833636
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0102773A HUP0102773A3 (en) | 1998-06-12 | 1999-06-09 | Tetrahydronaphthyridinil-carboxamides having anti-convulsant activity, process for their preparation and pharmaceutical compositions containing the same |
Country Status (31)
| Country | Link |
|---|---|
| US (2) | US6410555B1 (hu) |
| EP (1) | EP1084122B1 (hu) |
| JP (1) | JP2002518390A (hu) |
| KR (1) | KR20010052792A (hu) |
| CN (1) | CN1311789A (hu) |
| AP (1) | AP2000002009A0 (hu) |
| AR (1) | AR018656A1 (hu) |
| AT (1) | ATE252579T1 (hu) |
| AU (1) | AU750470B2 (hu) |
| BG (1) | BG105126A (hu) |
| BR (1) | BR9911110A (hu) |
| CA (1) | CA2334900A1 (hu) |
| CO (1) | CO5040081A1 (hu) |
| CZ (1) | CZ293010B6 (hu) |
| DE (1) | DE69912278T2 (hu) |
| EA (1) | EA200100033A1 (hu) |
| ES (1) | ES2209524T3 (hu) |
| GB (1) | GB9812683D0 (hu) |
| HU (1) | HUP0102773A3 (hu) |
| ID (1) | ID27593A (hu) |
| IL (1) | IL140171A0 (hu) |
| MA (1) | MA26646A1 (hu) |
| NO (1) | NO20006269L (hu) |
| NZ (1) | NZ508799A (hu) |
| PE (1) | PE20000727A1 (hu) |
| PL (1) | PL344791A1 (hu) |
| SK (1) | SK18962000A3 (hu) |
| TR (1) | TR200003694T2 (hu) |
| TW (1) | TW495510B (hu) |
| WO (1) | WO1999065903A1 (hu) |
| ZA (1) | ZA200007397B (hu) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9812683D0 (en) * | 1998-06-12 | 1998-08-12 | Smithkline Beecham Plc | Novel compounds |
| EP1243263B1 (en) * | 2001-03-21 | 2002-11-27 | Schwarz Pharma Ag | Novel use of a peptide class of compound for treating allodynia or other different types of chronic or phantom pain |
| EP1945639A1 (en) * | 2005-11-04 | 2008-07-23 | Pfizer Limited | Tetrahydronaphthyridine derivative |
| EP2888247B1 (en) * | 2012-08-27 | 2020-03-25 | Array Biopharma, Inc. | Serine/threonine kinase inhibitors for the treatment of hyperproliferative diseases |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9112721D0 (en) | 1991-06-13 | 1991-07-31 | Smithkline Beecham Plc | Novel treatment |
| CA2258238A1 (en) * | 1996-06-17 | 1997-12-24 | John David Harling | Substituted benzamide derivatives and their use as anticonvulsants |
| GB9711257D0 (en) * | 1997-05-30 | 1997-07-30 | Smithkline Beecham Plc | Novel compounds |
| GB9812683D0 (en) * | 1998-06-12 | 1998-08-12 | Smithkline Beecham Plc | Novel compounds |
-
1998
- 1998-06-12 GB GBGB9812683.2A patent/GB9812683D0/en not_active Ceased
-
1999
- 1999-06-09 NZ NZ508799A patent/NZ508799A/en unknown
- 1999-06-09 ES ES99957056T patent/ES2209524T3/es not_active Expired - Lifetime
- 1999-06-09 BR BR9911110-1A patent/BR9911110A/pt not_active IP Right Cessation
- 1999-06-09 TR TR2000/03694T patent/TR200003694T2/xx unknown
- 1999-06-09 EA EA200100033A patent/EA200100033A1/ru unknown
- 1999-06-09 CA CA002334900A patent/CA2334900A1/en not_active Abandoned
- 1999-06-09 CZ CZ20004611A patent/CZ293010B6/cs not_active IP Right Cessation
- 1999-06-09 KR KR1020007014099A patent/KR20010052792A/ko not_active Application Discontinuation
- 1999-06-09 WO PCT/GB1999/001826 patent/WO1999065903A1/en not_active Application Discontinuation
- 1999-06-09 JP JP2000554728A patent/JP2002518390A/ja active Pending
- 1999-06-09 ID IDW20002580A patent/ID27593A/id unknown
- 1999-06-09 DE DE69912278T patent/DE69912278T2/de not_active Expired - Fee Related
- 1999-06-09 IL IL14017199A patent/IL140171A0/xx unknown
- 1999-06-09 US US09/719,335 patent/US6410555B1/en not_active Expired - Fee Related
- 1999-06-09 PL PL99344791A patent/PL344791A1/xx not_active Application Discontinuation
- 1999-06-09 EP EP99957056A patent/EP1084122B1/en not_active Expired - Lifetime
- 1999-06-09 AU AU42800/99A patent/AU750470B2/en not_active Ceased
- 1999-06-09 HU HU0102773A patent/HUP0102773A3/hu unknown
- 1999-06-09 SK SK1896-2000A patent/SK18962000A3/sk unknown
- 1999-06-09 AP APAP/P/2000/002009A patent/AP2000002009A0/en unknown
- 1999-06-09 AT AT99957056T patent/ATE252579T1/de not_active IP Right Cessation
- 1999-06-09 CN CN99809413A patent/CN1311789A/zh active Pending
- 1999-06-10 MA MA25618A patent/MA26646A1/fr unknown
- 1999-06-10 AR ARP990102772A patent/AR018656A1/es not_active Application Discontinuation
- 1999-06-11 TW TW088109749A patent/TW495510B/zh active
- 1999-06-11 CO CO99036865A patent/CO5040081A1/es unknown
- 1999-06-11 PE PE1999000519A patent/PE20000727A1/es not_active Application Discontinuation
-
2000
- 2000-12-11 NO NO20006269A patent/NO20006269L/no not_active Application Discontinuation
- 2000-12-12 ZA ZA200007397A patent/ZA200007397B/xx unknown
-
2001
- 2001-01-08 BG BG105126A patent/BG105126A/xx unknown
-
2002
- 2002-05-23 US US10/154,997 patent/US6762192B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA26861A1 (fr) | Inhibiteurs non peptidiques de la liaison cellulaire sous la dependance de vla-4 utiles dans le traitement des maladies inflammatoires, auto-immunes et respiratoires | |
| HUP0300195A2 (hu) | Heterociklusos nátrium/proton-csere inhibitorok és ezeket tartalmazó gyógyszerkészítmények | |
| HUP0401291A2 (hu) | 4'-helyettesített nukleozidok | |
| MY114926A (en) | N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists | |
| TR200400342T4 (tr) | Farnezil protein transferazı önlemek için kinolin türevleri. | |
| MY141661A (en) | 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
| BG106020A (en) | Inhibitors of impdh enzyme | |
| HUP0004225A2 (hu) | Piridinszármazékok és alkalmazásuk gyógyszerkészítmények előállítására, valamint a vegyületeket tartalmazó gyógyszerkészítmények | |
| HUP0400241A2 (hu) | Hatóanyagként triaza-spiro[5.5]undekán-származékokat tartalmazó gyógyszerkészítmények | |
| HUP0301625A2 (hu) | Réztartalmú amin-oxidáz inhibitor hatású 1,3,4-oxadiazin-vegyületek, eljárás az előállításukra és alkalmazásuk gyógyszerkészítmények előállítására | |
| HUP0004238A2 (hu) | Farnezil-transzferáz inhibitor hatású imidazolszármazékok és eljárás előállításukra, valamint a vegyületeket tartalmazó gyógyszerkészítmények | |
| HUP0401984A2 (hu) | A 4. tipusú foszfodiészteráz enzim aktivitását gátló inhibitorok alkalmazása gyógyszerkészítmények előállítására és más hatóanyagokkal alkotott kombinációik | |
| AU5895496A (en) | Phenyldihydrobenzofurans | |
| HUP0204246A2 (hu) | Új tiazolo[4,5-d]pirimidin-származékok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| HUP0100885A2 (hu) | Fungicid hatású 7-aril-triazolopirimidinek | |
| HUP0004596A2 (hu) | Szerotonin 1A receptorra hatással lévő arilpiperazinok és a vegyületeket tartalmazó gyógyászati készítmények valamint intermedierjeik | |
| AU2013395A (en) | 11,21-bisphenyl-19-norpregnane derivatives | |
| HUP0100558A2 (hu) | S-Oxid- és S,S-dioxid-tetrahidrotiopirán-fenil-oxazolidinon-származékok, e vegyületek alkalmazása gyógyászati készítmények előállítására, valamint eljárás e vegyületek gátló hatásának meghatározására humán-monoamin-oxidázzal szemben | |
| HUP9700005A2 (hu) | 2-Ureido-benzamid-származékok és ilyeneket hatóanyagként tartalmazó gyógyszerkészítmények | |
| EP1228072A4 (en) | PDGF RECEPTOR KINASE INHIBITING COMPOUNDS, THEIR PRODUCTION, CLEANING AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS | |
| CY2462B1 (en) | Cyclohexyl dihydrobenzofuranes. | |
| HUP0100184A2 (hu) | Szubsztituált 2-(benzil-amino)-2-fenil-acetamid-vegyületek és ezeket tartalmazó gyógyszerkészítmények | |
| MXPA04003611A (es) | Piperidina- y piperazinacetaminas como inhibidores de la 17 beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades androgeno-dependientes. | |
| HUP0102773A2 (hu) | Antikonvulzáns hatású tetrahidronaftiridinil-karboxamidok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| HUP0104963A2 (hu) | Bőrbetegségek kezelésére szolgáló készítmények |